FFOXFundX Future Fund Opportunities ETF
Seeks to provide capital appreciation.
By Fund X · Launched 2025
Annual Cost
1.02%
#5,020 of 5,562 · expensive
Fund Size
$220M
#2,233 of 5,562 · mid-size
Return (1Y)Goal
+18.9%
Track Record
1 year
#4,442 of 5,562 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,848+18.5%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 27.4% of fund✓ well diversified
iShares Russell Mid-Cap Growth
7.4%
iShares S&P Small-Cap 600 Grow
4.9%
Guardant Health Inc
2.1%
Ionis Pharmaceuticals Inc
2.0%
Penumbra Inc
2.0%
Globus Medical Inc
2.0%
Millicom International Cellula
1.9%
TechnipFMC PLC
1.8%
Advanced Drainage Systems Inc
1.7%
Natera Inc
1.7%
Asset allocation
Stocks
96.9%
Cash
3.2%
By sector
Technology
22.4%
Industrials
22.0%
Healthcare
21.1%
Consumer Cyclical
14.1%
Financial Services
7.8%
Consumer Defensive
5.3%
Basic Materials
3.6%
Communication
2.1%
Other
1.4%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
17.6%Moderate
Year-on-year price swings
Max drawdown
-12.4%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to provide capital appreciation.
- Strategy
- Actively managed ETF investing in equity securities of companies positioned to benefit from long-term megatrends. Focuses on themes like technology, consumer preferences, and sustainability.
- Inception date
- June 9, 2025
- Fund family
- Fund X
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed FFOX. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19